Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-11.56	14.87	16.82
Graham Fair Price	43.36	44452.34	31008.38
PEG	-79.73	0.08	-0.37
Price/Book	2.00	0.99	0.97
Price/Cash Flow	-55.46	21.22	47.65
Prices/Earnings	-47.90	7.86	15.10
Price/Sales	5.73	2.48	2.35
Price/FCF	-55.46	21.22	47.65
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	11.57	0.22	0.19
Operating Margin	69.58	0.11	0.07
ROA	99.39	0.01	< 0.005
ROE	0.02	0.03	95.77
ROIC	0.01	0.02	55.39
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	0.06	-54.47
Dividends QOQ	-0.21	-1.00	-382.47
EBIT QOQ	-0.40	0.68	67.19
EPS QOQ	-0.40	1.03	157.05
FCF QOQ	-0.67	1.35	101.58
Revenue QOQ	0.03	-0.01	-58.91
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	4.43	5.39	21.73
Days Sales Outstanding (DSO)	49.61	53.03	6.90
Inventory Turnover	20.31	16.68	-17.85
Debt/Capitalization	0.47	0.47	0.41
Quick Ratio	0.61	0.65	6.91
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	51658.54	52928.17	2.46
Cash	8225.07	9747.43	18.51
Capex	-4633.99	-2775.87	40.10
Free Cash Flow	1048.34	2459.67	134.63
Revenue	21279.51	21033.79	-1.15
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.94	0.98	4.02
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.98	6.91	-13.45
Naive Interpretation	Member

06 - Financial Health · Bad

Rating